tirzepatide and vision loss Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Diabetes: Tirzepatide May Lower Risk

Affordability drives semaglutide use While recent studies have suggested that certain GLP-1 medicines may offer additional health benefits, cost continues to play a major role in determining which treatment patients receive

The maximum recommended dose for Mounjaro and Zepbound is 15mg a week, though not everyone requires this dose to see results

The SURMOUNT-OSA results The SURMOUNT-OSA trial enrolled adults with moderate-to-severe obstructive sleep apnea and a body mass index of 30 or higher

It is a concern if these are being used by those of a healthy BMI to slim down further. As always, Dr Touroni says healthy, sustainable long-term weight management via a healthy, balanced diet is always the best approach

Methods We performed a nationwide register-based cohort study using an active-comparator, new-user design

Prescription A licensed medical provider will recommend the right treatment for you